img

Global Measles Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Measles Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

The global Measles Vaccine market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Measles Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Measles Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Measles Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034..
The global key manufacturers of Measles Vaccine include GSK, Sanofi-Pasteur, Merck, Novartis, Pfizer, Serum Institute of India, China National Biotech Group, Bavarian Nordic and Emergent Biosolutions, etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of Measles Vaccine, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Measles Vaccine by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Measles Vaccine market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Measles Vaccine market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


GSK
Sanofi-Pasteur
Merck
Novartis
Pfizer
Serum Institute of India
China National Biotech Group
Bavarian Nordic
Emergent Biosolutions
Medimmune
Johnson & Johnson
CSL Limited
By Type
Mumps Measles Rubella Vaccine, Live (MMR-II)
Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
By Application
Children
Adults
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Measles Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Measles Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Measles Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Measles Vaccine Definition
1.2 Market by Type
1.2.1 Global Measles Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Mumps Measles Rubella Vaccine, Live (MMR-II)
1.2.3 Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
1.3 Market Segment by Application
1.3.1 Global Measles Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Children
1.3.3 Adults
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Measles Vaccine Sales
2.1 Global Measles Vaccine Revenue Estimates and Forecasts 2018-2034
2.2 Global Measles Vaccine Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Measles Vaccine Revenue by Region
2.3.1 Global Measles Vaccine Revenue by Region (2018-2024)
2.3.2 Global Measles Vaccine Revenue by Region (2024-2034)
2.4 Global Measles Vaccine Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Measles Vaccine Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Measles Vaccine Sales Quantity by Region
2.6.1 Global Measles Vaccine Sales Quantity by Region (2018-2024)
2.6.2 Global Measles Vaccine Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Measles Vaccine Sales Quantity by Manufacturers
3.1.1 Global Measles Vaccine Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Measles Vaccine Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Measles Vaccine Sales in 2022
3.2 Global Measles Vaccine Revenue by Manufacturers
3.2.1 Global Measles Vaccine Revenue by Manufacturers (2018-2024)
3.2.2 Global Measles Vaccine Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Measles Vaccine Revenue in 2022
3.3 Global Measles Vaccine Sales Price by Manufacturers
3.4 Global Key Players of Measles Vaccine, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Measles Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Measles Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Measles Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Measles Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Measles Vaccine Sales Quantity by Type
4.1.1 Global Measles Vaccine Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Measles Vaccine Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Measles Vaccine Sales Quantity Market Share by Type (2018-2034)
4.2 Global Measles Vaccine Revenue by Type
4.2.1 Global Measles Vaccine Historical Revenue by Type (2018-2024)
4.2.2 Global Measles Vaccine Forecasted Revenue by Type (2024-2034)
4.2.3 Global Measles Vaccine Revenue Market Share by Type (2018-2034)
4.3 Global Measles Vaccine Price by Type
4.3.1 Global Measles Vaccine Price by Type (2018-2024)
4.3.2 Global Measles Vaccine Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Measles Vaccine Sales Quantity by Application
5.1.1 Global Measles Vaccine Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Measles Vaccine Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Measles Vaccine Sales Quantity Market Share by Application (2018-2034)
5.2 Global Measles Vaccine Revenue by Application
5.2.1 Global Measles Vaccine Historical Revenue by Application (2018-2024)
5.2.2 Global Measles Vaccine Forecasted Revenue by Application (2024-2034)
5.2.3 Global Measles Vaccine Revenue Market Share by Application (2018-2034)
5.3 Global Measles Vaccine Price by Application
5.3.1 Global Measles Vaccine Price by Application (2018-2024)
5.3.2 Global Measles Vaccine Price Forecast by Application (2024-2034)
6 North America
6.1 North America Measles Vaccine Sales by Company
6.1.1 North America Measles Vaccine Revenue by Company (2018-2024)
6.1.2 North America Measles Vaccine Sales Quantity by Company (2018-2024)
6.2 North America Measles Vaccine Market Size by Type
6.2.1 North America Measles Vaccine Sales Quantity by Type (2018-2034)
6.2.2 North America Measles Vaccine Revenue by Type (2018-2034)
6.3 North America Measles Vaccine Market Size by Application
6.3.1 North America Measles Vaccine Sales Quantity by Application (2018-2034)
6.3.2 North America Measles Vaccine Revenue by Application (2018-2034)
6.4 North America Measles Vaccine Market Size by Country
6.4.1 North America Measles Vaccine Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Measles Vaccine Revenue by Country (2018-2034)
6.4.3 North America Measles Vaccine Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Measles Vaccine Sales by Company
7.1.1 Europe Measles Vaccine Sales Quantity by Company (2018-2024)
7.1.2 Europe Measles Vaccine Revenue by Company (2018-2024)
7.2 Europe Measles Vaccine Market Size by Type
7.2.1 Europe Measles Vaccine Sales Quantity by Type (2018-2034)
7.2.2 Europe Measles Vaccine Revenue by Type (2018-2034)
7.3 Europe Measles Vaccine Market Size by Application
7.3.1 Europe Measles Vaccine Sales Quantity by Application (2018-2034)
7.3.2 Europe Measles Vaccine Revenue by Application (2018-2034)
7.4 Europe Measles Vaccine Market Size by Country
7.4.1 Europe Measles Vaccine Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Measles Vaccine Revenue by Country (2018-2034)
7.4.3 Europe Measles Vaccine Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Measles Vaccine Sales by Company
8.1.1 China Measles Vaccine Sales Quantity by Company (2018-2024)
8.1.2 China Measles Vaccine Revenue by Company (2018-2024)
8.2 China Measles Vaccine Market Size by Type
8.2.1 China Measles Vaccine Sales Quantity by Type (2018-2034)
8.2.2 China Measles Vaccine Revenue by Type (2018-2034)
8.3 China Measles Vaccine Market Size by Application
8.3.1 China Measles Vaccine Sales Quantity by Application (2018-2034)
8.3.2 China Measles Vaccine Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Measles Vaccine Sales by Company
9.1.1 APAC Measles Vaccine Sales Quantity by Company (2018-2024)
9.1.2 APAC Measles Vaccine Revenue by Company (2018-2024)
9.2 APAC Measles Vaccine Market Size by Type
9.2.1 APAC Measles Vaccine Sales Quantity by Type (2018-2034)
9.2.2 APAC Measles Vaccine Revenue by Type (2018-2034)
9.3 APAC Measles Vaccine Market Size by Application
9.3.1 APAC Measles Vaccine Sales Quantity by Application (2018-2034)
9.3.2 APAC Measles Vaccine Revenue by Application (2018-2034)
9.4 APAC Measles Vaccine Market Size by Region
9.4.1 APAC Measles Vaccine Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Measles Vaccine Revenue by Region (2018-2034)
9.4.3 APAC Measles Vaccine Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Measles Vaccine Sales by Company
10.1.1 Middle East, Africa and Latin America Measles Vaccine Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Measles Vaccine Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Measles Vaccine Market Size by Type
10.2.1 Middle East, Africa and Latin America Measles Vaccine Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Measles Vaccine Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Measles Vaccine Market Size by Application
10.3.1 Middle East, Africa and Latin America Measles Vaccine Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Measles Vaccine Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Measles Vaccine Market Size by Country
10.4.1 Middle East, Africa and Latin America Measles Vaccine Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Measles Vaccine Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Measles Vaccine Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 GSK
11.1.1 GSK Company Information
11.1.2 GSK Overview
11.1.3 GSK Measles Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 GSK Measles Vaccine Products and Services
11.1.5 GSK Measles Vaccine SWOT Analysis
11.1.6 GSK Recent Developments
11.2 Sanofi-Pasteur
11.2.1 Sanofi-Pasteur Company Information
11.2.2 Sanofi-Pasteur Overview
11.2.3 Sanofi-Pasteur Measles Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Sanofi-Pasteur Measles Vaccine Products and Services
11.2.5 Sanofi-Pasteur Measles Vaccine SWOT Analysis
11.2.6 Sanofi-Pasteur Recent Developments
11.3 Merck
11.3.1 Merck Company Information
11.3.2 Merck Overview
11.3.3 Merck Measles Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Merck Measles Vaccine Products and Services
11.3.5 Merck Measles Vaccine SWOT Analysis
11.3.6 Merck Recent Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Overview
11.4.3 Novartis Measles Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Novartis Measles Vaccine Products and Services
11.4.5 Novartis Measles Vaccine SWOT Analysis
11.4.6 Novartis Recent Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Overview
11.5.3 Pfizer Measles Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Pfizer Measles Vaccine Products and Services
11.5.5 Pfizer Measles Vaccine SWOT Analysis
11.5.6 Pfizer Recent Developments
11.6 Serum Institute of India
11.6.1 Serum Institute of India Company Information
11.6.2 Serum Institute of India Overview
11.6.3 Serum Institute of India Measles Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Serum Institute of India Measles Vaccine Products and Services
11.6.5 Serum Institute of India Measles Vaccine SWOT Analysis
11.6.6 Serum Institute of India Recent Developments
11.7 China National Biotech Group
11.7.1 China National Biotech Group Company Information
11.7.2 China National Biotech Group Overview
11.7.3 China National Biotech Group Measles Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 China National Biotech Group Measles Vaccine Products and Services
11.7.5 China National Biotech Group Measles Vaccine SWOT Analysis
11.7.6 China National Biotech Group Recent Developments
11.8 Bavarian Nordic
11.8.1 Bavarian Nordic Company Information
11.8.2 Bavarian Nordic Overview
11.8.3 Bavarian Nordic Measles Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 Bavarian Nordic Measles Vaccine Products and Services
11.8.5 Bavarian Nordic Measles Vaccine SWOT Analysis
11.8.6 Bavarian Nordic Recent Developments
11.9 Emergent Biosolutions
11.9.1 Emergent Biosolutions Company Information
11.9.2 Emergent Biosolutions Overview
11.9.3 Emergent Biosolutions Measles Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 Emergent Biosolutions Measles Vaccine Products and Services
11.9.5 Emergent Biosolutions Measles Vaccine SWOT Analysis
11.9.6 Emergent Biosolutions Recent Developments
11.10 Medimmune
11.10.1 Medimmune Company Information
11.10.2 Medimmune Overview
11.10.3 Medimmune Measles Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.10.4 Medimmune Measles Vaccine Products and Services
11.10.5 Medimmune Measles Vaccine SWOT Analysis
11.10.6 Medimmune Recent Developments
11.11 Johnson & Johnson
11.11.1 Johnson & Johnson Company Information
11.11.2 Johnson & Johnson Overview
11.11.3 Johnson & Johnson Measles Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.11.4 Johnson & Johnson Measles Vaccine Products and Services
11.11.5 Johnson & Johnson Recent Developments
11.12 CSL Limited
11.12.1 CSL Limited Company Information
11.12.2 CSL Limited Overview
11.12.3 CSL Limited Measles Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.12.4 CSL Limited Measles Vaccine Products and Services
11.12.5 CSL Limited Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Measles Vaccine Value Chain Analysis
12.2 Measles Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Measles Vaccine Production Mode & Process
12.4 Measles Vaccine Sales and Marketing
12.4.1 Measles Vaccine Sales Channels
12.4.2 Measles Vaccine Distributors
12.5 Measles Vaccine Customers
13 Market Dynamics
13.1 Measles Vaccine Industry Trends
13.2 Measles Vaccine Market Drivers
13.3 Measles Vaccine Market Challenges
13.4 Measles Vaccine Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Measles Vaccine Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Mumps Measles Rubella Vaccine, Live (MMR-II)
Table 3. Major Manufacturers of Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
Table 4. Global Measles Vaccine Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Measles Vaccine Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Measles Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Measles Vaccine Revenue Market Share by Region (2018-2024)
Table 8. Global Measles Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 9. Global Measles Vaccine Revenue Market Share by Region (2024-2034)
Table 10. Global Measles Vaccine Sales Quantity by Region: 2018 VS 2022 VS 2034 (K MT)
Table 11. Global Measles Vaccine Sales by Region (2018-2024) & (K MT)
Table 12. Global Measles Vaccine Sales Market Share by Region (2018-2024)
Table 13. Global Measles Vaccine Sales by Region (2024-2034) & (K MT)
Table 14. Global Measles Vaccine Sales Market Share by Region (2024-2034)
Table 15. Global Measles Vaccine Sales Quantity by Manufacturers (2018-2024) & (K MT)
Table 16. Global Measles Vaccine Sales Quantity Share by Manufacturers (2018-2024)
Table 17. Global Measles Vaccine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Measles Vaccine Revenue Share by Manufacturers (2018-2024)
Table 19. Global Measles Vaccine Price by Manufacturers 2018-2024 (USD/MT)
Table 20. Global Key Players of Measles Vaccine, Industry Ranking, 2021 VS 2022
Table 21. Global Measles Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Measles Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Measles Vaccine as of 2022)
Table 23. Global Key Manufacturers of Measles Vaccine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Measles Vaccine, Product Offered and Application
Table 25. Global Key Manufacturers of Measles Vaccine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Measles Vaccine Sales Quantity by Type (2018-2024) & (K MT)
Table 28. Global Measles Vaccine Sales Quantity by Type (2024-2034) & (K MT)
Table 29. Global Measles Vaccine Sales Quantity Share by Type (2018-2024)
Table 30. Global Measles Vaccine Sales Quantity Share by Type (2024-2034)
Table 31. Global Measles Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Measles Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Measles Vaccine Revenue Share by Type (2018-2024)
Table 34. Global Measles Vaccine Revenue Share by Type (2024-2034)
Table 35. Measles Vaccine Price by Type (2018-2024) & (USD/MT)
Table 36. Global Measles Vaccine Price Forecast by Type (2024-2034) & (USD/MT)
Table 37. Global Measles Vaccine Sales Quantity by Application (2018-2024) & (K MT)
Table 38. Global Measles Vaccine Sales Quantity by Application (2024-2034) & (K MT)
Table 39. Global Measles Vaccine Sales Quantity Share by Application (2018-2024)
Table 40. Global Measles Vaccine Sales Quantity Share by Application (2024-2034)
Table 41. Global Measles Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Measles Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Measles Vaccine Revenue Share by Application (2018-2024)
Table 44. Global Measles Vaccine Revenue Share by Application (2024-2034)
Table 45. Measles Vaccine Price by Application (2018-2024) & (USD/MT)
Table 46. Global Measles Vaccine Price Forecast by Application (2024-2034) & (USD/MT)
Table 47. North America Measles Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 48. North America Measles Vaccine Sales Quantity by Company (2018-2024) & (K MT)
Table 49. North America Measles Vaccine Sales Quantity by Type (2018-2024) & (K MT)
Table 50. North America Measles Vaccine Sales Quantity by Type (2024-2034) & (K MT)
Table 51. North America Measles Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 52. North America Measles Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 53. North America Measles Vaccine Sales Quantity by Application (2018-2024) & (K MT)
Table 54. North America Measles Vaccine Sales Quantity by Application (2024-2034) & (K MT)
Table 55. North America Measles Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 56. North America Measles Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 57. North America Measles Vaccine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 58. North America Measles Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 59. North America Measles Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 60. North America Measles Vaccine Sales Quantity by Country (2018-2024) & (K MT)
Table 61. North America Measles Vaccine Sales Quantity by Country (2024-2034) & (K MT)
Table 62. Europe Measles Vaccine Sales Quantity by Company (2018-2024) & (K MT)
Table 63. Europe Measles Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 64. Europe Measles Vaccine Sales Quantity by Type (2018-2024) & (K MT)
Table 65. Europe Measles Vaccine Sales Quantity by Type (2024-2034) & (K MT)
Table 66. Europe Measles Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 67. Europe Measles Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 68. Europe Measles Vaccine Sales Quantity by Application (2018-2024) & (K MT)
Table 69. Europe Measles Vaccine Sales Quantity by Application (2024-2034) & (K MT)
Table 70. Europe Measles Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 71. Europe Measles Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 72. Europe Measles Vaccine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 73. Europe Measles Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 74. Europe Measles Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 75. Europe Measles Vaccine Sales Quantity by Country (2018-2024) & (K MT)
Table 76. Europe Measles Vaccine Sales Quantity by Country (2024-2034) & (K MT)
Table 77. China Measles Vaccine Sales Quantity by Company (2018-2024) & (K MT)
Table 78. China Measles Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 79. China Measles Vaccine Sales Quantity by Type (2018-2024) & (K MT)
Table 80. China Measles Vaccine Sales Quantity by Type (2024-2034) & (K MT)
Table 81. China Measles Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 82. China Measles Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 83. China Measles Vaccine Sales Quantity by Application (2018-2024) & (K MT)
Table 84. China Measles Vaccine Sales Quantity by Application (2024-2034) & (K MT)
Table 85. China Measles Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 86. China Measles Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 87. APAC Measles Vaccine Sales Quantity by Company (2018-2024) & (K MT)
Table 88. APAC Measles Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 89. APAC Measles Vaccine Sales Quantity by Type (2018-2024) & (K MT)
Table 90. APAC Measles Vaccine Sales Quantity by Type (2024-2034) & (K MT)
Table 91. APAC Measles Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 92. APAC Measles Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 93. APAC Measles Vaccine Sales Quantity by Application (2018-2024) & (K MT)
Table 94. APAC Measles Vaccine Sales Quantity by Application (2024-2034) & (K MT)
Table 95. APAC Measles Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 96. APAC Measles Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 97. APAC Measles Vaccine Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 98. APAC Measles Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 99. APAC Measles Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 100. APAC Measles Vaccine Sales Quantity by Region (2018-2024) & (K MT)
Table 101. APAC Measles Vaccine Sales Quantity by Region (2024-2034) & (K MT)
Table 102. Middle East, Africa and Latin America Measles Vaccine Sales Quantity by Company (2018-2024) & (K MT)
Table 103. Middle East, Africa and Latin America Measles Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Measles Vaccine Sales Quantity by Type (2018-2024) & (K MT)
Table 105. Middle East, Africa and Latin America Measles Vaccine Sales Quantity by Type (2024-2034) & (K MT)
Table 106. Middle East, Africa and Latin America Measles Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Measles Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 108. Middle East, Africa and Latin America Measles Vaccine Sales Quantity by Application (2018-2024) & (K MT)
Table 109. Middle East, Africa and Latin America Measles Vaccine Sales Quantity by Application (2024-2034) & (K MT)
Table 110. Middle East, Africa and Latin America Measles Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 111. Middle East, Africa and Latin America Measles Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Measles Vaccine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 113. Middle East, Africa and Latin America Measles Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 114. Middle East, Africa and Latin America Measles Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Measles Vaccine Sales Quantity by Country (2018-2024) & (K MT)
Table 116. Middle East, Africa and Latin America Measles Vaccine Sales Quantity by Country (2024-2034) & (K MT)
Table 117. GSK Company Information
Table 118. GSK Description and Overview
Table 119. GSK Measles Vaccine Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 120. GSK Measles Vaccine Product and Services
Table 121. GSK Measles Vaccine SWOT Analysis
Table 122. GSK Recent Developments
Table 123. Sanofi-Pasteur Company Information
Table 124. Sanofi-Pasteur Description and Overview
Table 125. Sanofi-Pasteur Measles Vaccine Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 126. Sanofi-Pasteur Measles Vaccine Product and Services
Table 127. Sanofi-Pasteur Measles Vaccine SWOT Analysis
Table 128. Sanofi-Pasteur Recent Developments
Table 129. Merck Company Information
Table 130. Merck Description and Overview
Table 131. Merck Measles Vaccine Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 132. Merck Measles Vaccine Product and Services
Table 133. Merck Measles Vaccine SWOT Analysis
Table 134. Merck Recent Developments
Table 135. Novartis Company Information
Table 136. Novartis Description and Overview
Table 137. Novartis Measles Vaccine Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 138. Novartis Measles Vaccine Product and Services
Table 139. Novartis Measles Vaccine SWOT Analysis
Table 140. Novartis Recent Developments
Table 141. Pfizer Company Information
Table 142. Pfizer Description and Overview
Table 143. Pfizer Measles Vaccine Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 144. Pfizer Measles Vaccine Product and Services
Table 145. Pfizer Measles Vaccine SWOT Analysis
Table 146. Pfizer Recent Developments
Table 147. Serum Institute of India Company Information
Table 148. Serum Institute of India Description and Overview
Table 149. Serum Institute of India Measles Vaccine Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 150. Serum Institute of India Measles Vaccine Product and Services
Table 151. Serum Institute of India Measles Vaccine SWOT Analysis
Table 152. Serum Institute of India Recent Developments
Table 153. China National Biotech Group Company Information
Table 154. China National Biotech Group Description and Overview
Table 155. China National Biotech Group Measles Vaccine Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 156. China National Biotech Group Measles Vaccine Product and Services
Table 157. China National Biotech Group Measles Vaccine SWOT Analysis
Table 158. China National Biotech Group Recent Developments
Table 159. Bavarian Nordic Company Information
Table 160. Bavarian Nordic Description and Overview
Table 161. Bavarian Nordic Measles Vaccine Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 162. Bavarian Nordic Measles Vaccine Product and Services
Table 163. Bavarian Nordic Measles Vaccine SWOT Analysis
Table 164. Bavarian Nordic Recent Developments
Table 165. Emergent Biosolutions Company Information
Table 166. Emergent Biosolutions Description and Overview
Table 167. Emergent Biosolutions Measles Vaccine Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 168. Emergent Biosolutions Measles Vaccine Product and Services
Table 169. Emergent Biosolutions Measles Vaccine SWOT Analysis
Table 170. Emergent Biosolutions Recent Developments
Table 171. Medimmune Company Information
Table 172. Medimmune Description and Overview
Table 173. Medimmune Measles Vaccine Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 174. Medimmune Measles Vaccine Product and Services
Table 175. Medimmune Measles Vaccine SWOT Analysis
Table 176. Medimmune Recent Developments
Table 177. Johnson & Johnson Company Information
Table 178. Johnson & Johnson Description and Overview
Table 179. Johnson & Johnson Measles Vaccine Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 180. Johnson & Johnson Measles Vaccine Product and Services
Table 181. Johnson & Johnson Recent Developments
Table 182. CSL Limited Company Information
Table 183. CSL Limited Description and Overview
Table 184. CSL Limited Measles Vaccine Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 185. CSL Limited Measles Vaccine Product and Services
Table 186. CSL Limited Recent Developments
Table 187. Key Raw Materials Lists
Table 188. Raw Materials Key Suppliers Lists
Table 189. Measles Vaccine Distributors List
Table 190. Measles Vaccine Customers List
Table 191. Measles Vaccine Market Trends
Table 192. Measles Vaccine Market Drivers
Table 193. Measles Vaccine Market Challenges
Table 194. Measles Vaccine Market Restraints
Table 195. Research Programs/Design for This Report
Table 196. Key Data Information from Secondary Sources
Table 197. Key Data Information from Primary Sources
List of Figures
Figure 1. Measles Vaccine Product Picture
Figure 2. Global Measles Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Measles Vaccine Market Share by Type in 2022 & 2034
Figure 4. Mumps Measles Rubella Vaccine, Live (MMR-II) Product Picture
Figure 5. Mumps Measles Rubella and Varicella Virus Vaccine (Proquad) Product Picture
Figure 6. Global Measles Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 7. Global Measles Vaccine Market Share by Application in 2022 & 2034
Figure 8. Children
Figure 9. Adults
Figure 10. Measles Vaccine Report Years Considered
Figure 11. Global Measles Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 12. Global Measles Vaccine Revenue 2018-2034 (US$ Million)
Figure 13. Global Measles Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 14. Global Measles Vaccine Sales Quantity 2018-2034 (K MT)
Figure 15. Global Measles Vaccine Sales Quantity Market Share by Region (2018-2024)
Figure 16. Global Measles Vaccine Sales Quantity Market Share by Region (2024-2034)
Figure 17. North America Measles Vaccine Sales Quantity YoY (2018-2034) & (K MT)
Figure 18. North America Measles Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 19. Europe Measles Vaccine Sales Quantity YoY (2018-2034) & (K MT)
Figure 20. Europe Measles Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 21. China Measles Vaccine Sales Quantity YoY (2018-2034) & (K MT)
Figure 22. China Measles Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 23. APAC Measles Vaccine Sales Quantity YoY (2018-2034) & (K MT)
Figure 24. APAC Measles Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Measles Vaccine Sales Quantity YoY (2018-2034) & (K MT)
Figure 26. Middle East, Africa and Latin America Measles Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 27. The Top 10 and Top 5 Players Market Share by Measles Vaccine Sales Quantity in 2022
Figure 28. The Top 10 and Top 5 Players Market Share by Measles Vaccine Revenue in 2022
Figure 29. Measles Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Measles Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 31. Global Measles Vaccine Revenue Market Share by Type (2018-2034)
Figure 32. Global Measles Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 33. Global Measles Vaccine Revenue Market Share by Application (2018-2034)
Figure 34. North America Measles Vaccine Revenue Market Share by Company in 2022
Figure 35. North America Measles Vaccine Sales Quantity Market Share by Company in 2022
Figure 36. North America Measles Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 37. North America Measles Vaccine Revenue Market Share by Type (2018-2034)
Figure 38. North America Measles Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 39. North America Measles Vaccine Revenue Market Share by Application (2018-2034)
Figure 40. North America Measles Vaccine Revenue Share by Country (2018-2034)
Figure 41. North America Measles Vaccine Sales Quantity Share by Country (2018-2034)
Figure 42. U.S. Measles Vaccine Revenue (2018-2034) & (US$ Million)
Figure 43. Canada Measles Vaccine Revenue (2018-2034) & (US$ Million)
Figure 44. Europe Measles Vaccine Sales Quantity Market Share by Company in 2022
Figure 45. Europe Measles Vaccine Revenue Market Share by Company in 2022
Figure 46. Europe Measles Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 47. Europe Measles Vaccine Revenue Market Share by Type (2018-2034)
Figure 48. Europe Measles Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 49. Europe Measles Vaccine Revenue Market Share by Application (2018-2034)
Figure 50. Europe Measles Vaccine Revenue Share by Country (2018-2034)
Figure 51. Europe Measles Vaccine Sales Quantity Share by Country (2018-2034)
Figure 52. Germany Measles Vaccine Revenue (2018-2034) & (US$ Million)
Figure 53. France Measles Vaccine Revenue (2018-2034) & (US$ Million)
Figure 54. U.K. Measles Vaccine Revenue (2018-2034) & (US$ Million)
Figure 55. Italy Measles Vaccine Revenue (2018-2034) & (US$ Million)
Figure 56. Russia Measles Vaccine Revenue (2018-2034) & (US$ Million)
Figure 57. China Measles Vaccine Sales Quantity Market Share by Company in 2022
Figure 58. China Measles Vaccine Revenue Market Share by Company in 2022
Figure 59. China Measles Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 60. China Measles Vaccine Revenue Market Share by Type (2018-2034)
Figure 61. China Measles Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 62. China Measles Vaccine Revenue Market Share by Application (2018-2034)
Figure 63. APAC Measles Vaccine Sales Quantity Market Share by Company in 2022
Figure 64. APAC Measles Vaccine Revenue Market Share by Company in 2022
Figure 65. APAC Measles Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 66. APAC Measles Vaccine Revenue Market Share by Type (2018-2034)
Figure 67. APAC Measles Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 68. APAC Measles Vaccine Revenue Market Share by Application (2018-2034)
Figure 69. APAC Measles Vaccine Revenue Share by Region (2018-2034)
Figure 70. APAC Measles Vaccine Sales Quantity Share by Region (2018-2034)
Figure 71. Japan Measles Vaccine Revenue (2018-2034) & (US$ Million)
Figure 72. South Korea Measles Vaccine Revenue (2018-2034) & (US$ Million)
Figure 73. China Taiwan Measles Vaccine Revenue (2018-2034) & (US$ Million)
Figure 74. Southeast Asia Measles Vaccine Revenue (2018-2034) & (US$ Million)
Figure 75. India Measles Vaccine Revenue (2018-2034) & (US$ Million)
Figure 76. Middle East, Africa and Latin America Measles Vaccine Sales Quantity Market Share by Company in 2022
Figure 77. Middle East, Africa and Latin America Measles Vaccine Revenue Market Share by Company in 2022
Figure 78. Middle East, Africa and Latin America Measles Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 79. Middle East, Africa and Latin America Measles Vaccine Revenue Market Share by Type (2018-2034)
Figure 80. Middle East, Africa and Latin America Measles Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 81. Middle East, Africa and Latin America Measles Vaccine Revenue Market Share by Application (2018-2034)
Figure 82. Middle East, Africa and Latin America Measles Vaccine Sales Quantity Share by Country (2018-2034)
Figure 83. Middle East, Africa and Latin America Measles Vaccine Revenue Share by Country (2018-2034)
Figure 84. Brazil Measles Vaccine Revenue (2018-2034) & (US$ Million)
Figure 85. Mexico Measles Vaccine Revenue (2018-2034) & (US$ Million)
Figure 86. Turkey Measles Vaccine Revenue (2018-2034) & (US$ Million)
Figure 87. Israel Measles Vaccine Revenue (2018-2034) & (US$ Million)
Figure 88. GCC Countries Measles Vaccine Revenue (2018-2034) & (US$ Million)
Figure 89. Measles Vaccine Value Chain
Figure 90. Measles Vaccine Production Process
Figure 91. Channels of Distribution (Direct Vs Distribution)
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries